Studies in our lab aimed at testing this hypothesis by examining the effect of suppressed Sox17 expression on the expression of Runx1 in the lung and in progenitor cells of animals with pulmonary hypertension and patients with PAH are ongoing. This evidence concerns the gene RUNX1 and pulmonary hypertension.